Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-…
작성자 채식영양
작성일 17-01-01 00:00
조회 0
댓글 0
본문
M. Isaacs, KT. Tonks and JR. Greenfield (2017). Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors. Internal medicine journal, 47(6), 701-704. https://doi.org/10.1111/imj.13442
[Abstract]
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are an increasingly prescribed class of medication for type 2 diabetes mellitus. Euglycaemic diabetic ketoacidosis (euDKA) has been reported in association with SGLT2i use. Clinicians need to understand how to recognise and treat this complication. We describe three cases of euDKA in patients treated with SGLT2i.
댓글목록 0
등록된 댓글이 없습니다.
